AMAT vs NKTR · P/E 56, rev $24.04B vs rev $21.0M
Applied Materials Inc (AMAT) versus Nektar Therapeutics (NKTR) — a side-by-side from cached financials, not a winner call.
Applied Materials Inc (AMAT) is a semiconductor equipment & materials company listed on NASDAQ. It is led by Gary E. Dickerson.
Nektar Therapeutics (NKTR) is a biotechnology company listed on US.
Latest reported AMAT revenue for 2026-07-26 was $24.04B. Net income was $7.37B. AMAT currently screens at market cap $470.75B and trailing P/E 55.8.
Latest reported NKTR revenue for 2026-06-30 was $21.0M. Net income was -$85.5M. Revenue was up 93.3% from 2026-03-31 to 2026-06-30. NKTR currently screens at market cap $307.2M.
AMAT currently screens at market cap $470.75B and trailing P/E 55.8. NKTR currently screens at market cap $307.2M.
Not investment advice. Open the AMAT and NKTR stock pages for the full models.
Not investment advice.